Replies to post #57 on Biotech Values

[DewDiligence]

Squalamine molecular structure:

A few people expressed an interest in Squalamine’s structure, so I’ve extracted the slide from GENR’s pdf file which shows it (#38):



Do we have any medicinal chemists in the house?

[DewDiligence]

GENR (if anyone still cares): on the ymb they are assuming that higher doses will improve Evizon’s tepid efficacy to date in U.S. trials, but I wouldn’t bet on it.

See slide #52 (at bottom) in #msg-1605364. The numbers speak for themselves and the slide’s caption says: “No Notable Difference in Study Eyes Response By Dose at End of Therapy and Follow-up.”

FWIW